Overview of vaccine adjuvants
Authors:
- Rushit N. LodayaRLRushit N. Lodaya
- Sonia GregorySGSonia Gregory
- Mansoor M. AmijiMAMansoor M. Amiji
- Derek T. O'HAganDODerek T. O'HAgan
- 1 January 2022
- book chapter
- Published by Elsevier
- p. 9-25
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsionExpert Review of Vaccines, 2012
- The development of vaccines: how the past led to the futureNature Reviews Microbiology, 2011
- Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88Proceedings of the National Academy of Sciences, 2011
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunityVaccine, 2011
- Fundamentals of Vaccine ImmunologyJournal of Global Infectious Diseases, 2011
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccineJournal of Pharmaceutical Sciences, 2009
- The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activityEuropean Journal of Immunology, 2008
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cellsJournal of Experimental Medicine, 2008
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJournal of the American Academy of Dermatology, 2004